DSAEK rapidly restores corneal clarity in young CHED patients

Article

Descemet-stripping automated endothelial keratoplasty (DSAEK) efficiently restores corneal clarity with minimal complications in young congenital hereditary endothelial dystrophy (CHED) patients

Descemet-stripping automated endothelial keratoplasty (DSAEK) efficiently restores corneal clarity with minimal complications in young congenital hereditary endothelial dystrophy (CHED) patients, according to a study published in the Archives of Ophthalmology.

A team led by Dr Massimo Busin, Villa Serena Hospital, Forlí, Italy, examined the medical records of 15 eyes of 8 CHED patients who underwent DSAEK. A detailed ophthalmic examination of all patients was conducted preoperatively and at each postoperative visit. All patients underwent standard DSAEK, except in patients younger than 12 months. These patients didn't have their Descemet membrane removed.

The mean patient age was 9 years and the average follow-up period was 15.9 months. Graft detachment was found in 4 cases and was treated by rebubbling.

Within 1 week after surgery all corneas were clear. Preoperatively, six eyes were able to fix and follow and 3 eyes could fix and follow 1 week postoperatively. Preoperative best-corrected visual acuity was recorded as 20/200 or less in 6 eyes. Best-corrected visual acuity of 20/40 or better was achieved postoperatively.

The study advises conducting DSAEK at an earlier age in order to provide improved visual development and possibly prevent amblyopia.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.